JERUSALEM, Dec 30 (Reuters) - Nvidia (NVDA.O), opens new tab is in advanced talks to buy Israel-based AI startup AI21 Labs for as much as $3 billion, the Calcalist financial daily reported on Tuesday.

Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...

Mohsen Baqery is a Staff Writer at GameRant based in Turkey. He mainly covers video game news and industry features while occasionally publishing guides and listicles. Mohsen started his journey into ...

Some of the most significant software supply chain incidents over the past year were carried out by threat actors who exploited vulnerabilities in GitHub, the global repository widely used by software ...

Hundreds of trojanized versions of well-known packages such as Zapier, ENS Domains, PostHog, and Postman have been planted in the npm registry in a new Shai-Hulud supply-chain campaign. The malicious ...

Elon Musk’s artificial-intelligence company, xAI, is in advanced talks to raise $15 billion in new equity at a $230 billion valuation, according to people familiar with the plans. The new valuation ...

GitHub launches Agent HQ to unite Codex, Claude, and Jules. Developers can now manage multiple AI agents side by side. Mission Control gives coders one command center for all AI tools. Today, at ...

Advanced Micro Devices surges after a landmark AI chip partnership with OpenAI, positioning AMD as a viable alternative to NVIDIA in the AI space. The OpenAI deal is expected to deliver tens of ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

Supernal sacked its C suite and its planned S-A2 tiltrotor air taxi in September. Credit: Supernal This has been a breakthrough year for the nascent advanced air mobility industry, as the leading ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...